Recombinant Human MAP2K3, His-tagged
Cat.No. : | MAP2K3-29204TH |
Product Overview : | Human MEK3, with an N terminal His tag; 338 amino acids with a predicted MWt 38.3kDa including tag corresponding to the full length isoform 1 or fragment of isoform 3 |
- Specification
- Gene Information
- Related Products
Description : | The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is activated by mitogenic and environmental stress, and participates in the MAP kinase-mediated signaling cascade. It phosphorylates and thus activates MAPK14/p38-MAPK. This kinase can be activated by insulin, and is necessary for the expression of glucose transporter. Expression of RAS oncogene is found to result in the accumulation of the active form of this kinase, which thus leads to the constitutive activation of MAPK14, and confers oncogenic transformation of primary cells. The inhibition of this kinase is involved in the pathogenesis of Yersina pseudotuberculosis. Multiple alternatively spliced transcript variants that encode distinct isoforms have been reported for this gene. |
Protein length : | 328 amino acids |
Conjugation : | HIS |
Molecular Weight : | 38.300kDa inclusive of tags |
Source : | E. coli |
Tissue specificity : | Abundant expression is seen in the skeletal muscle. It is also widely expressed in other tissues. |
Form : | Liquid |
Purity : | >90% by SDS-PAGE |
Storage buffer : | Preservative: NoneConstituents: 10% Glycerol, 20mM Tris HCl, pH 8 |
Storage : | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. |
Sequences of amino acids : | MGSSHHHHHH SSGLVPRGSH MSKPPAPNPTPPRNLDSRTF ITIGDRNFEV EADDLVTISE LGRGAYGVVEKVRHAQSGTI MAVKRIRATV NSQEQKRLLM DLDINMRTVDCFYTVTFYGA LFREGDVWIC MELMDTSLDK FYRKVLDKNMTIPEDILGEI AVSIVRALEH LHSKLSVIHR DVKPSNVLIN KEGHVKMCDF GISGYLVDSV AKTMDAGCKP YMAPERINPELNQKGYNVKS DVWSLGITMI EMAILRFPYE SWGTPFQQLKQVVEEPSPQL PADRFSPEFV DFTAQCLRKN PAERMSYLELMEHPFFTLHK TKKTDIAAFV KEILGEDS |
Sequence Similarities : | Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase subfamily.Contains 1 protein kinase domain. |
Gene Name : | MAP2K3 mitogen-activated protein kinase kinase 3 [ Homo sapiens ] |
Official Symbol : | MAP2K3 |
Synonyms : | MAP2K3; mitogen-activated protein kinase kinase 3; PRKMK3; dual specificity mitogen-activated protein kinase kinase 3; dual specificity mitogen activated protein kinase kinase 3; MAP kinase kinase 3; MAPK/ERK kinase 3; MAPKK3; MEK3; MKK3; |
Gene ID : | 5606 |
mRNA Refseq : | NM_002756 |
Protein Refseq : | NP_002747 |
MIM : | 602315 |
Uniprot ID : | P46734 |
Chromosome Location : | 17q11.2 |
Pathway : | Activated TLR4 signalling, organism-specific biosystem; Amyotrophic lateral sclerosis (ALS), organism-specific biosystem; Amyotrophic lateral sclerosis (ALS), conserved biosystem; CDC42 signaling events, organism-specific biosystem; CXCR3-mediated signaling events, organism-specific biosystem; |
Function : | ATP binding; MAP kinase kinase activity; nucleotide binding; protein binding; protein kinase binding; |
Products Types
◆ Recombinant Protein | ||
Map2k3-3922M | Recombinant Mouse Map2k3 Protein, Myc/DDK-tagged | +Inquiry |
MAP2K3-5324M | Recombinant Mouse MAP2K3 Protein, His (Fc)-Avi-tagged | +Inquiry |
MAP2K3-2484R | Recombinant Rhesus Macaque MAP2K3 Protein, His (Fc)-Avi-tagged | +Inquiry |
MAP2K3-3202H | Recombinant Human MAP2K3 protein, His-SUMO-tagged | +Inquiry |
MAP2K3-9500M | Recombinant Mouse MAP2K3 Protein | +Inquiry |
◆ Lysates | ||
MAP2K3-4510HCL | Recombinant Human MAP2K3 293 Cell Lysate | +Inquiry |
MAP2K3-4511HCL | Recombinant Human MAP2K3 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionEvidence suggests that MAP2K3 expression levels can correlate with disease prognosis, aiding in predicting outcomes for some cancers.
Clinical trials investigating the efficacy of targeting MAP2K3 in cancer treatments are underway, assessing its potential as a therapeutic target.
MAP2K3 dysregulation has been observed in various cancers, including colorectal, lung, and breast cancers.
While specific inhibitors for MAP2K3 are under development, some drugs indirectly impact its activity by targeting related proteins in the signaling cascade.
Expression levels of MAP2K3 can be assessed through techniques like immunohistochemistry or molecular analyses in patient samples.
Customer Reviews (3)
Write a reviewThe manufacturer's commitment to customer satisfaction extends beyond providing the protein itself.
They offer comprehensive technical support, including responsive customer service, availability of product information, and timely delivery of the product.
MAP2K3 protein offers numerous advantages in trials, ranging from its stability and bioactivity to the manufacturer's commitment to customer support.
Ask a Question for All MAP2K3 Products
Required fields are marked with *
My Review for All MAP2K3 Products
Required fields are marked with *
Inquiry Basket